Arsanis Pharmaceuticals: A Revolutionary Approach To Infectious Pathogens [Seeking Alpha]
Actelis Networks, Inc. (ASNS)
Last actelis networks, inc. earnings: 11/9 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.arsanis.com/investor-relations
Company Research
Source: Seeking Alpha
Arsanis Pharmaceuticals: A Revolutionary Approach To Infectious PathogensSummaryThe company is developing monoclonal antibodies directed against bacteria and viruses.The key R&D program is ASN100, which is directed against 6 cytotoxins critical to Staphylococcus Aureus pathogenesis.An independent data review committee will conduct an interim analysis in the first half of 2018 to assess the success probability of the trial as designed (a near-term catalyst).We are initiating coverage on Arsanis stock with a Buy rating and a price target of $35.
Show less
Read more
Impact Snapshot
Event Time:
ASNS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ASNS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ASNS alerts
High impacting Actelis Networks, Inc. news events
Weekly update
A roundup of the hottest topics
ASNS
News
- ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) [Yahoo! Finance]Yahoo! Finance
- Actelis Networks Signs Binding Term Sheet to Acquire Quality Industrial Corporation and Expand Operations in Critical Energy Industry [Yahoo! Finance]Yahoo! Finance
- Actelis Networks Signs Binding Term Sheet to Acquire Quality Industrial Corporation and Expand Operations in Critical Energy IndustryGlobeNewswire
- QIND Signs Binding Term Sheet with Nasdaq Listed Actelis Networks [Yahoo! Finance]Yahoo! Finance
- Actelis Networks Reports Fiscal First Quarter 2024 [Yahoo! Finance]Yahoo! Finance
ASNS
Sec Filings
- 5/23/24 - Form 8-K
- 5/23/24 - Form 8-K
- 5/15/24 - Form 8-K
- ASNS's page on the SEC website